BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25817215)

  • 1. Fluorescent and Bioluminescent Nanoprobes for In Vitro and In Vivo Detection of Matrix Metalloproteinase Activity.
    Lee H; Kim YP
    BMB Rep; 2015 Jun; 48(6):313-8. PubMed ID: 25817215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMP-2-responsive fluorescent nanoprobes for enhanced selectivity of tumor cell uptake and imaging.
    Sun L; Xie S; Ji X; Zhang J; Wang D; Lee SJ; Lee H; He H; Yang VC
    Biomater Sci; 2018 Sep; 6(10):2619-2626. PubMed ID: 30109310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive optical imaging of matrix metalloproteinase activity with albumin-based fluorogenic nanoprobes during angiogenesis in a mouse hindlimb ischemia model.
    Ryu JH; Shin JY; Kim SA; Kang SW; Kim H; Kang S; Choi K; Kwon IC; Kim BS; Kim K
    Biomaterials; 2013 Sep; 34(28):6871-81. PubMed ID: 23773822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
    Levin M; Udi Y; Solomonov I; Sagi I
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical biology for understanding matrix metalloproteinase function.
    Knapinska A; Fields GB
    Chembiochem; 2012 Sep; 13(14):2002-20. PubMed ID: 22933318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing the Biodistribution of Radiofluorinated Barbiturate Tracers for Matrix Metalloproteinase Imaging by Introduction of Fluorescent Dyes as Pharmacokinetic Modulators.
    Schwegmann K; Hohn M; Hermann S; Schäfers M; Riemann B; Haufe G; Wagner S; Breyholz HJ
    Bioconjug Chem; 2020 Apr; 31(4):1117-1132. PubMed ID: 32181649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular recognition of proteolytic activity in metastatic cancer cells using fluorogenic gold nanoprobes.
    Hong Y; Ku M; Heo D; Hwang S; Lee E; Park J; Choi J; Lee HJ; Seo M; Lee EJ; Yook JI; Haam S; Huh YM; Yoon DS; Suh JS; Yang J
    Biosens Bioelectron; 2014 Jul; 57():171-8. PubMed ID: 24583688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-sensitive fluorescent nanoprobes for detection of matrix metalloproteinases and low pH in a 3D tumor microenvironment.
    Rainu S; Parameswaran S; Krishnakumar S; Singh N
    J Mater Chem B; 2022 Jul; 10(28):5388-5401. PubMed ID: 35770560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Synthetic Matrix Metalloproteinase Inhibitors by Fluorogenic Substrate Assay.
    Lively TJ; Bosco DB; Khamis ZI; Sang QX
    Methods Mol Biol; 2016; 1406():161-70. PubMed ID: 26820953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Structure and function of matrix metalloproteinases].
    Olszyński K; Zimowska M
    Postepy Biochem; 2009; 55(1):76-84. PubMed ID: 19514468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and cancer - roles in threat and therapy.
    Yadav L; Puri N; Rastogi V; Satpute P; Ahmad R; Kaur G
    Asian Pac J Cancer Prev; 2014; 15(3):1085-91. PubMed ID: 24606423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemically engineered persistent luminescence nanoprobes for bioimaging.
    Lécuyer T; Teston E; Ramirez-Garcia G; Maldiney T; Viana B; Seguin J; Mignet N; Scherman D; Richard C
    Theranostics; 2016; 6(13):2488-2524. PubMed ID: 27877248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of H-aggregation on activatable MMP-2-specific probes for optical imaging.
    Lebel R; Bonin MA; Zriba R; Radulska A; Neugebauer W; Lepage M
    Contrast Media Mol Imaging; 2012; 7(3):328-37. PubMed ID: 22539403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near infrared receptor-targeted nanoprobes for early diagnosis of cancers.
    Cheng K; Cheng Z
    Curr Med Chem; 2012; 19(28):4767-85. PubMed ID: 22873665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autofluorescent gelatin nanoparticles as imaging probes to monitor matrix metalloproteinase metabolism of cancer cells.
    Cai B; Rao L; Ji X; Bu LL; He Z; Wan D; Yang Y; Liu W; Guo S; Zhao XZ
    J Biomed Mater Res A; 2016 Nov; 104(11):2854-60. PubMed ID: 27376586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "One-step" detection of matrix metalloproteinase activity using a fluorogenic peptide probe-immobilized diagnostic kit.
    Ryu JH; Lee A; Lee S; Ahn CH; Park JW; Leary JF; Park S; Kim K; Kwon IC; Youn IC; Choi K
    Bioconjug Chem; 2010 Jul; 21(7):1378-84. PubMed ID: 20575580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation and silencing of matrix metalloproteinases.
    Fu X; Parks WC; Heinecke JW
    Semin Cell Dev Biol; 2008 Feb; 19(1):2-13. PubMed ID: 17689277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Light-Activated Nanoprobes for Biosensing and Imaging.
    Li M; Zhao J; Chu H; Mi Y; Zhou Z; Di Z; Zhao M; Li L
    Adv Mater; 2019 Nov; 31(45):e1804745. PubMed ID: 30276873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of a novel hydroxamate based fluorescent photoprobe for imaging of matrix metalloproteinases.
    Faust A; Waschkau B; Waldeck J; Höltke C; Breyholz HJ; Wagner S; Kopka K; Schober O; Heindel W; Schäfers M; Bremer C
    Bioconjug Chem; 2009 May; 20(5):904-12. PubMed ID: 19374404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and Biological Attributes of Matrix Metalloproteinases.
    Cui N; Hu M; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.